ORPHAN DRUG-STYLE INCENTIVES FOR ANTI-ADDICTION DRUG R&D
Executive Summary
ORPHAN DRUG-STYLE INCENTIVES FOR ANTI-ADDICTION DRUG R&D could be added to the pending crime bill, Sens. Biden (D-Del.) and Hatch (R-Utah) agreed at a April 19 hearing before the Biden's Senate Judiciary Committee. Hatch said the measure would be designed to provide pharmaceutical companies with incentives to develop anti- addiction medications in light of the high cost of drug development.